Aletheia
The Future of Molecular Testing Has Arrived.
A handheld molecular diagnostics technology that delivers lab-quality results in minutes anywhere, anytime
A Unique Point-of-Care Molecular Testing Platform
- Universal Platform
- Compatible with any pathogen or sample type
- Field-Ready Design
- Portable, rugged, and reusable analyzer
- Unmatched Speed - Rapid results in 12-45 minutes vs. hours/days for labs
- Market-Leading Price
- Value-based pricing; lower cost with multiplexing
- Multiplex Detection
- Up to 7 pathogens simultaneously
- PCR-accuracy (>98% sensitivity, >99% specificity) validated by TIER 1 Institutions
Seeking $20M to accelerate commercialization and product expansion A complete shift in detection - seamless workflow from sample prep to results & data analysis
A Unique Point-of-Care Molecular Testing Platform
- Universal Platform
- Compatible with any pathogen or sample type
- Field-Ready Design
- Portable, rugged, and reusable analyzer
- Unmatched Speed - Rapid results in 12-45 minutes vs. hours/days for labs
- Market-Leading Price
- Value-based pricing; lower cost with multiplexing
- Multiplex Detection
- Up to 7 pathogens simultaneously
- PCR-accuracy (>98% sensitivity, >99% specificity) validated by TIER 1 Institutions
Seeking $20M to accelerate commercialization and product expansion A complete shift in detection - seamless workflow from sample prep to results & data analysis
Fundraise Details
This section is only visible to registered investors. Log in or register as an accredited investor to view.
Ready to Ask For Funding for your company?
Post a Funding RequestKey Facts
- Industry
- {{model.industry | ffIndustry}}
- Location
- {{model.city_state}}
- Year Founded
- {{model.year_founded}}
- Monthly Income
- {{model.monthly_income | ffIncome}}
- Website
- {{model.homepage_url}}